Subgen AI (SUBGEN.ST) Stock Price

Subgen AI Price

OMX·CLOSED
0.03
​
Market closed

Over the last 3 years Subgen AI grew revenue by 87.3% annually, reaching 92,000.00 SEK. For Subgen AI, the net margin of -64,887.0% is up versus -132,321.4% a few years ago.

Subgen AI stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Subgen AI business model & stock analysis

AegirBio AB engages in the development and commercialization of drug monitoring tests. The company is headquartered in Lund, Skane. The company went IPO on 2020-06-26. The firm offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company aims to provide personalized treatment by tracking drugs levels in individuals. Aegirbio combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.

Frequently asked questions about Subgen AI

Converted at the current exchange rate, the Subgen AI share trades at 0.00 EUR (0.03 SEK).

The Subgen AI share (SUBGEN.ST) is listed on 3 stock exchanges, including: Frankfurt (52Q.F), Stockholm (AEGIR.ST).

The revenue cannot currently be calculated for Subgen AI.

The profit cannot currently be calculated for Subgen AI.

The P/E ratio cannot be calculated for Subgen AI at the moment.

The P/S cannot be calculated for Subgen AI currently.

The Eulerpool Quality Score for Subgen AI is 2/10.

The ISIN of Subgen AI is SE0026820854. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Subgen AI is A2P7ZC. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Subgen AI is SUBGEN.ST. The ticker symbol is used to trade Subgen AI shares on the stock exchange.

Fair ValueTerminal
0.03 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website aegirbio.com
Country
Sweden
Currency
SEK
Initial public offering
Jun 26, 2020
ISIN
SE0026820854
Cusip
W0R196176
Market capitalization
17.14 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.43
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-794.11 %
Last updated Oct 22, 2026, 6:15 PM

Subgen AI Peer Group

Subgen AI Ticker

FRANKFURT · 52Q.FSTOCKHOLM · AEGIR.STSTOCKHOLM · AEGIR.ST

All fundamentals and in-depth analysis of Subgen AI

Our stock analysis for Subgen AI stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Subgen AI. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.